The changing face of rheumatoid arthritis: sustained remission for all? (Q44508845)

3 December 2017

1 reference

title

The changing face of rheumatoid arthritis: sustained remission for all? (English)

1 reference

3 December 2017

1 reference

John D Isaacs

1

0 references

publication date

1 August 2010

1 reference

Nature Reviews Immunology

3 December 2017

published in

1 reference

3 December 2017

volume

10

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

605-611

1 reference

Current treatment paradigms in rheumatoid arthritis

3 December 2017

cites work

1 reference

Biologic therapies in rheumatology: lessons learned, future directions

21 January 2018

1 reference

Current concepts in the pathogenesis of early rheumatoid arthritis

31 March 2020

1 reference

Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.

31 March 2020

1 reference

Bone remodeling in rheumatic disease: a question of balance

31 March 2020

1 reference

Cardiovascular morbidity and mortality in rheumatoid arthritis

31 March 2020

1 reference

31 March 2020

1 reference

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

31 March 2020

1 reference

Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

31 March 2020

1 reference

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

31 March 2020

1 reference

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention

31 March 2020

1 reference

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

31 March 2020

1 reference

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

31 March 2020

1 reference

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial

31 March 2020

1 reference

Treatment of rheumatoid arthritis: state of the art 2009.

31 March 2020

1 reference

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

31 March 2020

1 reference

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score

31 March 2020

1 reference

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

31 March 2020

1 reference

Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials

31 March 2020

1 reference

Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment

31 March 2020

1 reference

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

31 March 2020

1 reference

Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment

31 March 2020

1 reference

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis.

31 March 2020

1 reference

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

31 March 2020

1 reference

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

31 March 2020

1 reference

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

31 March 2020

1 reference

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

31 March 2020

1 reference

T cell immunomodulation--the Holy Grail of therapeutic tolerance

31 March 2020

1 reference

Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: A population-based study

31 March 2020

1 reference

Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists

31 March 2020

1 reference

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

31 March 2020

1 reference

Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.

31 March 2020

1 reference

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors

31 March 2020

1 reference

Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies

31 March 2020

1 reference

Asymptomatic synovitis precedes clinically manifest arthritis

31 March 2020

1 reference

What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases

31 March 2020

1 reference

Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

31 March 2020

1 reference

Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial

31 March 2020

1 reference

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.

31 March 2020

1 reference

When does rheumatoid arthritis start and can it be stopped before it does?

31 March 2020

1 reference

Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease

31 March 2020

1 reference

Targeted ultrasound of the fifth metatarsophalangeal joint in an early inflammatory arthritis cohort

31 March 2020

1 reference

A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.

31 March 2020

1 reference

Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression

31 March 2020

1 reference

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

31 March 2020

1 reference

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis

31 March 2020

1 reference

Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse.

31 March 2020

1 reference

Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.

31 March 2020

1 reference

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

31 March 2020

1 reference

Genetic factors influencing the outcome of early arthritis--the role of sulphoxidation status

31 March 2020

1 reference

Genetic susceptibility to rheumatoid arthritis: an emerging picture

31 March 2020

1 reference

Interleukin-17 and type 17 helper T cells

31 March 2020

1 reference

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

31 March 2020

1 reference

The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases

31 March 2020

1 reference

Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

31 March 2020

1 reference

Osteoimmunology and the effects of the immune system on bone

31 March 2020

1 reference

Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis

31 March 2020

1 reference

Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies

31 March 2020

1 reference

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

31 March 2020

1 reference

12 December 2020

Treating to re-establish tolerance in inflammatory arthritis - lessons from other diseases

1 reference

12 December 2020

Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene

1 reference

12 December 2020

Development of a disease activity score based on judgment in clinical practice by rheumatologists.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI2804

1 reference

release_plj5priu5zgovclafmdgxnpvj4

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/plj5priu5zgovclafmdgxnpvj4

24 November 2022

mapped directly with Wikidata item

1 reference